Cargando…

Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak

BACKGROUND: The impact of some hasty medical decision made during the first wave of the Coronavirus Disease 2019 (COVID-19) remains unknown. We have evaluated the consequences of one of these precautionary measures: the withdrawal of the cyclin D-dependent kinases 4/6 inhibitor (CDK4/6i) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Sophie, Pflumio, Carole, Trensz, Philippe, Schaff-Wendling, Frederique, Weindling, Michal Kalish-, Fischbach, Cathie, Pierard, Laure, Limacher, Jean-Marc, Nader, Rita, Velten, Michel, Petit, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558751/ https://www.ncbi.nlm.nih.gov/pubmed/36414498 http://dx.doi.org/10.1016/j.clbc.2022.10.006

Ejemplares similares

Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer
por: Mallard, Joris, et al.
Publicado: (2022)

Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients
por: Mallard, Joris, et al.
Publicado: (2022)

Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol
por: Mallard, Joris, et al.
Publicado: (2020)

Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy
por: Hucteau, Elyse, et al.
Publicado: (2023)

The Impact of an Incidental Dose on Axillary Tumor Control and Toxicity in Localized Breast Cancer: A Retrospective Analysis
por: Schmitt, Martin, et al.
Publicado: (2022)

Endocrine Therapy Nonadherence and Discontinuation in Black and White Women
por: Wheeler, Stephanie B, et al.
Publicado: (2018)

Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy
por: Mallard, Joris, et al.
Publicado: (2022)

Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review
por: Moinard-Butot, Fabien, et al.
Publicado: (2023)

The Consequences of Mutations in the Reproductive Endocrine System
por: Choi, Donchan
Publicado: (2012)

Metabolic and Endocrine Consequences of Bariatric Surgery
por: Cornejo-Pareja, Isabel, et al.
Publicado: (2019)

Editorial: Endocrine consequences of sleep disorders
por: Uchima Koecklin, Karin Harumi, et al.
Publicado: (2023)

Consequences of the discontinuous replacement of radiated energy on the performance of LEP 200
por: Ruggiero, F
Publicado: (1990)

COVID‐19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS‐CoV‐2 Cluster During the First Wave of the COVID‐19 Pandemic
por: Martin, Sophie, et al.
Publicado: (2021)

Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?
por: Kemp, Anna, et al.
Publicado: (2014)

Consequence of the tumor-associated conversion to cyclin D1b
por: Augello, Michael A, et al.
Publicado: (2015)

Metabolic, Endocrine, and Immune Consequences of Sleep Deprivation
por: AlDabal, Laila, et al.
Publicado: (2011)

Editorial: Endocrine and metabolic consequences of childhood obesity
por: Molnár, Dénes, et al.
Publicado: (2022)

Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients
por: Carinato, Hélène, et al.
Publicado: (2021)

Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation
por: Bashour, Sami I., et al.
Publicado: (2017)

Discontinuation of carbamazepine due to concerns of long‐term consequences of enzyme induction
por: Mäkinen, Jussi, et al.
Publicado: (2018)

Consequences of a Missed History: A Case of Antidepressant Discontinuation Syndrome
por: Hameed, Sajid, et al.
Publicado: (2020)

Activation of Cyclin-Dependent Kinase 5 Is a Consequence of Cell Death
por: Ye, Yixia, et al.
Publicado: (2009)

Canard solutions in neural mass models: consequences on critical regimes
por: Köksal Ersöz, Elif, et al.
Publicado: (2021)

Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation
por: Smith, Karen Lisa, et al.
Publicado: (2022)

Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care
por: Krakower, Douglas, et al.
Publicado: (2019)

Ventricular Fibrillation: Potential Deadly Consequence of Discontinuation of Methimazole Prior to Radioiodine Ablation
por: Sikandar, Billal H, et al.
Publicado: (2021)

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
por: Lucasson, Florian, et al.
Publicado: (2022)

Editorial: Endocrine and metabolic consequences of childhood obesity, volume II
por: Mazur, Artur, et al.
Publicado: (2023)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
por: Lemij, Annelieke A., et al.
Publicado: (2022)

Chemical inhibitors of cyclin-dependent kinase (CDKi) improve pancreatic endocrine differentiation of iPS cells
por: Ning, Heming, et al.
Publicado: (2023)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

Identification of Lymphomyeloid Primitive Progenitor Cells in Fresh Human Cord Blood and in the Marrow of Nonobese Diabetic–Severe Combined Immunodeficient (NOD-SCID) Mice Transplanted with Human CD34(+) Cord Blood Cells
por: Robin, Catherine, et al.
Publicado: (1999)

Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
por: Dagenais, Gilles R, et al.
Publicado: (2021)

Cyclin-dependent kinase 4/6 inhibitor in combination with endocrine therapy versus endocrine therapy only for advanced breast cancer: a systematic review and meta-analysis
por: Xu, Zhi-Hong, et al.
Publicado: (2020)

Endocrine disruption in aquatic systems: up‐scaling research to address ecological consequences
por: Windsor, Fredric M., et al.
Publicado: (2017)

On the dynamics of the human endocrine pancreas and potential consequences for the development of type 1 diabetes
por: Skog, Oskar, et al.
Publicado: (2019)

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability
por: Kimmel, April D, et al.
Publicado: (2012)

A cross-sectional study clarifying profiles of patients with diabetes who discontinued pharmacotherapy: reasons and consequences
por: Tominaga, Yoshiko, et al.
Publicado: (2021)

Unintended consequences of healthcare reform in South Korea: evidence from a regression discontinuity in time design
por: Kim, Moon Joon
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhcjvc6ea99pqqup57i4saqntv